Paclitaxel
Paclitaxel is a chemically synthesized compound used for research and development purposes. It is a microtubule-stabilizing agent commonly employed in the study of cell biology and cancer research.
Lab products found in correlation
57 protocols using paclitaxel
Paclitaxel Dissolution and Dilution
Preparation of Paclitaxel-Albumin Formulation
Cell Cycle Analysis of Chemotherapeutics
Paclitaxel Delivery to Endothelial Cells
Example 3
Delivery of paclitaxel to endothelial cells and tissue was studied in vitro using cells grown on Matrigel™ coated cell culture plates. Human coronary endothelial cells (HCAECs, Lonza, Walkersville, Md.) were cultured in EGM™-2MV growth media (Lonza, Walkersville, Md.). One day prior to paclitaxel transfer studies, cells were seed in 96 well BD Matrigel™ Matrix Thin-Layer cell culture plates at 20,000 cells per well in 0.2 mL of medium. Suspensions of paclitaxel (LC Laboratories, Woburn, Mass.) in water were prepared at 11 mg/ml paclitaxel and with PEI (Polysciences, Warrington, Pa.; MW=750 kDa) or PAMAM, ethylene diamine core, gen 4, dendrimer (Sigma, Milwaukee, Wis.; 14,214 Da) at 0.96 mg/mL (92:8 w/w ratio) or iopromide at 11 mg/mL (IOPR, 1:1 w/w ratio). Suspensions were sonicated briefly prior to use. Resulting suspensions (5 μL) were added to the cell culture plates and incubated for 3 or 10 minutes. Suspensions were also added to Matrigel™ coated plates with medium but without cells. After incubation plates were rinsed three times with phosphate buffered saline (200 μL per well) and then allowed to dry overnight. paclitaxel remaining in plates was dissolved in methanol (250 μL) and quantified by HPLC. The amount of transferred paclitaxel is shown in
Paclitaxel Formulation for Intravenous Delivery
Antiproliferative Effects of Kinase Inhibitors
Synergistic Effects of Valproic Acid and Paclitaxel
Supplementary Fig. 1 can be found, in the online version, at
Drug administration schedule. (A) Single drug treatment and (B) combined drug treatment.
Evaluating Drug Combination Cytotoxicity
MTS Assay for Cell Proliferation Inhibition
Paclitaxel Modulates S. mansoni Infection
of 25 mg/kg of mice was IP administered one day after intravenous augmentation
of the mice (challenge) with S. mansoni eggs. The dose was
selected as per the prior report.17 (link) Control mice were given PBS only. In the chronic hypoxia model,
Paclitaxel was IP administered at a dose of 25 mg/kg of mice, at days 1 and 8
.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!